blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3664835

EP3664835 - METHODS AND COMPOSITIONS FOR PREPARING GENETICALLY ENGINEERED CELLS [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  19.09.2024
Database last updated on 14.12.2024
FormerGrant of patent is intended
Status updated on  15.05.2024
FormerExamination is in progress
Status updated on  19.04.2024
FormerGrant of patent is intended
Status updated on  17.12.2023
FormerExamination is in progress
Status updated on  01.12.2023
FormerGrant of patent is intended
Status updated on  24.07.2023
FormerExamination is in progress
Status updated on  19.06.2023
FormerGrant of patent is intended
Status updated on  06.02.2023
FormerExamination is in progress
Status updated on  26.11.2020
FormerRequest for examination was made
Status updated on  15.05.2020
FormerThe international publication has been made
Status updated on  16.02.2019
Formerunknown
Status updated on  11.09.2018
Most recent event   Tooltip25.10.2024Change - divisional application(s)published on 27.11.2024  [2024/48]
Applicant(s)For all designated states
Juno Therapeutics, Inc.
400 Dexter Avenue North, Suite 1200
Seattle, WA 98109 / US
[2020/25]
Inventor(s)01 / BONYHADI, Mark L.
400 Dexter Ave N Suite 1200
Seattle Washington 98109 / US
 [2020/25]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2024/43]
Former [2020/25]Goodfellow, Hugh Robin
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
Application number, filing date18760160.409.08.2018
[2020/25]
WO2018US46151
Priority number, dateUS201762543359P09.08.2017         Original published format: US 201762543359 P
[2020/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019032929
Date:14.02.2019
Language:EN
[2019/07]
Type: A1 Application with search report 
No.:EP3664835
Date:17.06.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 14.02.2019 takes the place of the publication of the European patent application.
[2020/25]
Type: B1 Patent specification 
No.:EP3664835
Date:23.10.2024
Language:EN
[2024/43]
Search report(s)International search report - published on:EP14.02.2019
ClassificationIPC:A61K39/00, C12N5/0783
[2020/25]
CPC:
C12N5/0636 (EP,KR,US); C12N15/86 (US); A61K35/17 (US);
A61K39/4611 (EP,KR,US); A61K39/4631 (EP,KR,US); A61K39/464412 (EP,KR,US);
A61K39/464417 (EP,KR,US); C07K16/2809 (KR); C07K16/2818 (KR);
C07K2317/622 (EP,KR); C07K2319/00 (EP); C12N2510/00 (EP,KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/25]
Extension statesBA06.03.2020
ME06.03.2020
Validation statesKH06.03.2020
MA06.03.2020
MD06.03.2020
TN06.03.2020
TitleGerman:VERFAHREN UND ZUSAMMENSETZUNGEN ZUR HERSTELLUNG GENETISCH VERÄNDERTER ZELLEN[2020/25]
English:METHODS AND COMPOSITIONS FOR PREPARING GENETICALLY ENGINEERED CELLS[2020/25]
French:PROCÉDÉS ET COMPOSITIONS DE PRÉPARATION DE CELLULES GÉNÉTIQUEMENT MODIFIÉES[2020/25]
Entry into regional phase06.03.2020National basic fee paid 
06.03.2020Designation fee(s) paid 
06.03.2020Examination fee paid 
Examination procedure06.03.2020Examination requested  [2020/25]
06.03.2020Date on which the examining division has become responsible
30.09.2020Amendment by applicant (claims and/or description)
25.11.2020Despatch of a communication from the examining division (Time limit: M06)
07.06.2021Reply to a communication from the examining division
05.08.2021Despatch of a communication from the examining division (Time limit: M04)
15.12.2021Reply to a communication from the examining division
08.04.2022Despatch of a communication from the examining division (Time limit: M04)
18.08.2022Reply to a communication from the examining division
07.02.2023Communication of intention to grant the patent
19.06.2023Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
25.07.2023Communication of intention to grant the patent
01.12.2023Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
18.12.2023Communication of intention to grant the patent
18.04.2024Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
16.05.2024Communication of intention to grant the patent
16.09.2024Fee for grant paid
16.09.2024Fee for publishing/printing paid
16.09.2024Receipt of the translation of the claim(s)
Divisional application(s)EP24207574.5
Fees paidRenewal fee
13.08.2020Renewal fee patent year 03
13.08.2021Renewal fee patent year 04
15.07.2022Renewal fee patent year 05
05.07.2023Renewal fee patent year 06
04.07.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XY]WO2012129514  (HUTCHINSON FRED CANCER RES [US], et al);
 [XY]WO2015164675  (JUNO THERAPEUTICS INC [US]);
by applicantUS8252592
 US4452773
 US4690915
 US4795698
 US5200084
 US5219740
 EP0452342
 WO9613593
 WO9618105
 WO9918129
 WO9960120
 WO0014257
 US6040177
 US6060273
 US6207453
 US6410319
 US6451995
 US2002131960
 US2002150914
 WO03020763
 WO03068201
 US2003170238
 US2003223994
 US2003235908
 WO2004033685
 US2004191260
 WO2006000830
 US2006034850
 US7070995
 US2007092530
 US2007116690
 US7265209
 US7354762
 US7446190
 US7446179
 US7446191
 WO2009072003
 US2009226474
 US2009304679
 WO2010033140
 US2011003380
 WO2011044186
 US7977095
 WO2012048341
 WO2012048340
 WO2012129514
 US8324353
 US8339645
 EP2537416
 US8389282
 US8398282
 WO2013071154
 US2013149337
 US8479118
 WO2013123061
 WO2013126726
 US2013287748
 WO2013166321
 US8617884
 WO2014031687
 WO2014055668
 US8802374
 WO2014144495
 US2014294841
 US8911993
 WO2016044227
 US2016152723
 WO2016090327
 WO2016090320
 WO2016090329
 WO2016090312
 WO2016176322
 US9528088
 US2017051035
 WO2017053902
 WO1991US08442
 WO1994US05601
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.